KYORIN Pharmaceutical Market Cap

KYORIN Pharmaceutical has a market cap or net worth of 92.27 billion as of January 21, 2026. Its market cap has increased by 11.69% in one year.

Market Cap

92.27B

Enterprise Value

99.57B

Revenue

133.68B

Ranking

n/a

PE Ratio

9.89

Stock Price

1,598.00

Market Cap Chart

Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 92.27B, an increase of 405.73%. That is a compound annual growth rate of 8.49%.

Market Cap History

Date	Market Cap	% Change
Jan 20, 2026	92.27B	4.49%
Dec 30, 2025	88.30B	2.13%
Dec 30, 2024	86.46B	-15.45%
Dec 29, 2023	102.26B	3.75%
Dec 30, 2022	98.56B	-6.82%
Dec 30, 2021	105.78B	-4.89%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	13.58T
HOYA Corporation	8.57T
Takeda Pharmaceutical Company	8.01T
Daiichi Sankyo Company	6.13T
Otsuka Holdings	4.76T
Astellas Pharma	4.02T
Terumo	3.25T
Shionogi &	2.44T

Market Cap Rankings